![Petter Björquist](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Petter Björquist
Director/Board Member at PHASE HOLOGRAPHIC IMAGING PHI AB
Petter Björquist active positions
Companies | Position | Start | End |
---|---|---|---|
PHASE HOLOGRAPHIC IMAGING PHI AB | Director/Board Member | - | - |
NovaHep AB
![]() NovaHep AB Miscellaneous Commercial ServicesCommercial Services NovaHep AB provides stem-cell research for gene therapy of liver diseases. Its main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The company was founded by Suchitra Sumitran-Holgersson and Jan Anders Holgersson in 2005 and is headquartered in Gothenburg, Sweden. | Chief Executive Officer | - | - |
Verigraft
![]() Verigraft BiotechnologyHealth Technology Verigraft engages in the development of personalized human tissues for transplantation. The company is headquartered in Gothenburg, Sweden. | Chief Executive Officer | 2014-01-31 | - |
Career history of Petter Björquist
Former positions of Petter Björquist
Companies | Position | Start | End |
---|---|---|---|
Takara Bio Europe AB
![]() Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Corporate Officer/Principal | 2002-07-31 | 2013-12-31 |
Statistics
International
Sweden | 5 |
Operational
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 1 |
Sectoral
Commercial Services | 3 |
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
PHASE HOLOGRAPHIC IMAGING PHI AB | Health Technology |
Private companies | 3 |
---|---|
NovaHep AB
![]() NovaHep AB Miscellaneous Commercial ServicesCommercial Services NovaHep AB provides stem-cell research for gene therapy of liver diseases. Its main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The company was founded by Suchitra Sumitran-Holgersson and Jan Anders Holgersson in 2005 and is headquartered in Gothenburg, Sweden. | Commercial Services |
Verigraft
![]() Verigraft BiotechnologyHealth Technology Verigraft engages in the development of personalized human tissues for transplantation. The company is headquartered in Gothenburg, Sweden. | Health Technology |
Takara Bio Europe AB
![]() Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Commercial Services |
- Stock Market
- Insiders
- Petter Björquist
- Experience